Reveal Surgical
Reveal Surgical develops AI-driven optical detection systems for tumor margin assessment and tissue characterization, combining AI, Raman Spectroscopy, and intuitive surgical probes. Their flagship product, the Sentry™, is an intraoperative platform designed for neurosurgery to provide real-time, in vivo identification of invasive cancer cells at sub-millimeter scale, improving surgical precision and patient outcomes. The company is ISO 13485 certified, emphasizing quality in medical device manufacturing, and collaborates with research partners and investors to advance tumor identification technology. Their technology aims to reduce cancer recurrence by enabling surgeons to detect cancerous tissue not visible with standard imaging, thus enhancing surgical decision-making and patient safety.
Reveal Surgical
Reveal Surgical develops AI-driven optical detection systems for tumor margin assessment and tissue characterization, combining AI, Raman Spectroscopy, and intuitive surgical probes. Their flagship product, the Sentry™, is an intraoperative platform designed for neurosurgery to provide real-time, in vivo identification of invasive cancer cells at sub-millimeter scale, improving surgical precision and patient outcomes. The company is ISO 13485 certified, emphasizing quality in medical device manufacturing, and collaborates with research partners and investors to advance tumor identification technology. Their technology aims to reduce cancer recurrence by enabling surgeons to detect cancerous tissue not visible with standard imaging, thus enhancing surgical decision-making and patient safety.